Skip to main content
Equibles

Caption Management, LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,457,000
+$1,457,000 QoQ
Shares Held
100,000
Ownership
0.013%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#76
of 242 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2026
CallValue
$4,758,562
CallShares
326,600
PutValue
$1,487,597
PutShares
102,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. SMMT ranks #34 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in SMMT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,457,000 100,000
2026-06-30 $1,487,597 102,100
2026-06-30 $4,758,562 326,600
2026-03-31 $568,800 30,000
2026-03-31 $4,360,800 230,000
2025-12-31 $4,197,600 240,000
2025-12-31 $2,186,250 125,000
2025-09-30 $2,582,500 125,000
2025-09-30 $4,245,630 205,500
2025-09-30 $583,934 28,264
2025-06-30 $5,687,186 267,255
2025-06-30 $13,319,152 625,900
2025-06-30 $3,479,280 163,500
2025-03-31 $192,900 10,000
2025-03-31 $192,900 10,000
2024-06-30 $3,892,980 499,100
2024-06-30 $5,644,860 723,700